Ampicillin-SB 1.5 GM Injection

Ampicillin-SB 1.5 GM Injection is a combination antibiotic containing Ampicillin (a penicillin-class antibiotic) and Sulbactam (a beta-lactamase inhibitor). This combination enhances antibacterial effectiveness by preventing resistance caused by beta-lactamase–producing bacteria.

It is indicated for the treatment of moderate to severe bacterial infections and is administered via Intramuscular (IM) or Intravenous (IV) route under medical supervision.

Specifications:

-

Active Ingredients: Ampicillin + Sulbactam

-

Strength: 1.5 GM

-

Form: Powder for Injection

-

Pack Type: Vial + WFI (Water for Injection)

-

Route: IM / IV Use

-

Usage: Hospital / Clinical use

Medical Uses:

-

Respiratory tract infections

-

Urinary tract infections (UTIs)

-

Skin and soft tissue infections

-

Intra-abdominal infections

-

Gynecological infections

-

Septicemia

-

Surgical prophylaxis

Key Features:

-

Broad-spectrum antibacterial coverage

-

Effective against beta-lactamase–producing organisms

-

Suitable for serious systemic infections

-

Hospital-grade injectable antibiotic

-

Combination therapy for enhanced efficacy

Benefits:

-

Fights resistant bacterial infections

-

Rapid systemic action

-

Suitable for severe infections requiring injectable therapy

-

Helps prevent complications from untreated infections

Dosage & Administration:

-

Administer strictly as prescribed by a qualified healthcare professional

-

Dose depends on infection severity and patient condition

-

Reconstitute with supplied WFI before administration

-

IM or IV administration only

Warnings:

-

Prescription only medicine

-

Do not use in patients allergic to penicillin antibiotics

-

Use cautiously in patients with kidney impairment

-

Complete full prescribed course

-

Not for self-administration

Possible Side Effects:

-

Injection site pain

-

Nausea or diarrhea

-

Allergic reactions (rash, swelling)

-

Rare severe hypersensitivity reactions

Seek immediate medical attention if allergic symptoms occur.